Evolution of Lung Cancer Treatment from Classical Chemotherapy to Advanced Immunotherapy-Reference-Cited by-同舟云学术

Evolution of Lung Cancer Treatment from Classical Chemotherapy to Advanced Immunotherapy

Published:2024 Issue: Volume: Page:25-43
ISSN:
Container-title:Immunotherapy Against Lung Cancer
language:en
Short-container-title:

Author:

Maheshkumar Subiksha,Prakash Diwahar,Subramanian Ashwin,Muthukumarasamy Gayathri Devi,Duraisamy Rishmitha,Gopal Gayathri,Muralidar Shibi,Ambi Senthil Visaga

Publisher

Springer Nature Singapore

Link

https://link.springer.com/content/pdf/10.1007/978-981-99-7141-1_3

Reference44 articles.

1. Alexander M, Kim SY, Cheng H (2020) Update 2020: management of non-small cell lung cancer. Lung 198(6):897–907. https://doi.org/10.1007/s00408-020-00407-5

2. Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim Y-C, Karapetis CS, Hiret S, Özgüroğlu M (2017) Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer. N Engl J Med 377(20):1919–1929. https://doi.org/10.1056/nejmoa1709937

3. Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim Y-C, Karapetis CS, Hiret S, Özgüroğlu M (2018) Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. N Engl J Med 379(24):2342–2350. https://doi.org/10.1056/nejmoa1809697

4. Bar J, Ofek E, Barshack I, Gottfried T, Zadok O, Kamer I, Urban D, Perelman M, Onn A (2019) Lung cancer transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer. Lung Cancer 138:109–115. https://doi.org/10.1016/j.lungcan.2019.09.025

5. Biermann JS, Chow W, Reed DR, Lucas D, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Budd GT, Curry WT, Didwania A, Fabbri N, Hornicek FJ, Kuechle JB, Lindskog D, Mayerson J, McGarry SV, Million L, Morris CD, Scavone JL (2017) NCCN guidelines insights: bone cancer, version 2.2017. J Natl Compr Cancer Netw 15(2):155–167. https://doi.org/10.6004/jnccn.2017.0017